Habiger David C purchased $100K of BSX
Habiger David C purchased 2,100 shares of BOSTON SCIENTIFIC CORP (BSX) at $47.59 on 2026-08-05.
How this was made
The 30-second read
Why it matters
The only disclosed new fact is the director’s open-market purchase details (shares, price, total value, and post-transaction holdings).
Market read
Traders may note insider buying as a mild sentiment input, but there is no accompanying fundamental or regulatory catalyst in the text.
What to watch
The Form 4 states no 10b5-1 plan, but the article provides no context on motivation, prior trading history, or whether the purchase size is meaningful versus typical director activity.
Background
The article is a primary-source SEC Form 4 insider transaction disclosure for Boston Scientific.
Ticker impact
SEC Form 4 shows director Habiger David C bought 2,100 shares of Boston Scientific at $47.5890 on 2026-08-05.
Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment.
The filing is an insider buy, but it is not tied to new company guidance, contracts, litigation, or regulatory actions in the text.
Market effects
No sector read-through is provided beyond a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Insider buys can be routine (compensation, diversification, or pre-planned liquidity needs) and may not reflect a new bullish thesis.
Key entities
- issuerBoston Scientific Corp
Subject of the Form 4 insider transaction disclosure.
- insiderHabiger David C
Director who purchased 2,100 shares on 2026-08-05.
